The mechanisms which lead to resistance due to the BM microenvironment in MM are soluble factor-mediated drug resistance (SFM-DR), including IL6 and cell-adhesion mediated drug resistance (CAM-DR), involving adhesion molecules (β1 integrins) [109]. Here, IL6 is linked to Miyoshi myopathy.